APA (7th ed.) Citation

Braess, J., Lengfelder, E., Uppenkamp, M., & Lablans, M. (2018). Sequential high-dose cytarabine and mitoxantrone (S-HAM) versus standard double induction in acute myeloid leukemia: A phase 3 study. Leukemia, 32(12), . https://doi.org/10.1038/s41375-018-0268-9

Chicago Style (17th ed.) Citation

Braess, Jan, Eva Lengfelder, Michael Uppenkamp, and Martin Lablans. "Sequential High-dose Cytarabine and Mitoxantrone (S-HAM) Versus Standard Double Induction in Acute Myeloid Leukemia: A Phase 3 Study." Leukemia 32, no. 12 (2018). https://doi.org/10.1038/s41375-018-0268-9.

MLA (9th ed.) Citation

Braess, Jan, et al. "Sequential High-dose Cytarabine and Mitoxantrone (S-HAM) Versus Standard Double Induction in Acute Myeloid Leukemia: A Phase 3 Study." Leukemia, vol. 32, no. 12, 2018, https://doi.org/10.1038/s41375-018-0268-9.